Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: New Pacer: TPL's Motion for Reconsider of Certain Aspects of Claim Const 9-10-12

At first glance, good news and bad news.

Good news: this whole DMA terminology bothered me with the (pardon the word but it is valid in this context) co-mingling of DMA and CPU explanations. TPL is trying to clarify and rectify any ambiguity.

Bad news: TPL is essentially acknowledging that they didn't do the fullest due diligence in their earlier research and presentations and now, a LONG time later, are scrambling to offset their oversight.

It'll be interesting to see how this turns out.

4
Sep 11, 2012 11:25AM
Share
New Message
Please login to post a reply